These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 3759592

  • 21. Effects of glutathione depletion using buthionine sulphoximine on the cytotoxicity of nitroaromatic compounds in mammalian cells in vitro.
    Hodgkiss RJ, Middleton RW.
    Biochem Pharmacol; 1985 Jun 15; 34(12):2175-8. PubMed ID: 4004936
    [Abstract] [Full Text] [Related]

  • 22. Glutathione depletion by DL-buthionine-SR-sulfoximine (BSO) potentiates X-ray-induced chromosome lesions after liquid holding recovery.
    Bertsche U, Schorn H.
    Radiat Res; 1986 Mar 15; 105(3):351-69. PubMed ID: 3754339
    [Abstract] [Full Text] [Related]

  • 23. Depletion of intracellular GSH and NPSH by buthionine sulfoximine and diethyl maleate: factors that influence enhancement of aerobic radiation response.
    Varnes ME, Biaglow JE, Roizin-Towle L, Hall EJ.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1229-33. PubMed ID: 6469743
    [Abstract] [Full Text] [Related]

  • 24. Combined effect of buthionine sulfoximine and cyclophosphamide upon murine tumours and bone marrow.
    Ono K, Komuro C, Tsutsui K, Shibamoto Y, Nishidai T, Takahashi M, Abe M, Shrieve DC.
    Br J Cancer; 1986 Nov 15; 54(5):749-54. PubMed ID: 3801271
    [Abstract] [Full Text] [Related]

  • 25. The effect of prolonged high dose misonidazole on tumor response to radiation.
    McNally NJ, de Ronde J, Hinchliffe M.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1281-5. PubMed ID: 6469751
    [Abstract] [Full Text] [Related]

  • 26. Effect of DL-buthionine-S,R-sulfoximine on the growth of EMT6 and RIF mouse tumors.
    Miller AC, Henderson BW.
    J Natl Cancer Inst; 1986 Aug 15; 77(2):505-10. PubMed ID: 3461211
    [Abstract] [Full Text] [Related]

  • 27. Effects of glutathione depletion by buthionine sulfoximine on the sensitivity of EMT6/SF cells to chemotherapy agents or X radiation.
    Shrieve DC, Harris JW.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1171-4. PubMed ID: 3744936
    [Abstract] [Full Text] [Related]

  • 28. Inhibition of the acute toxicity of methyl chloride in male B6C3F1 mice by glutathione depletion.
    Chellman GJ, White RD, Norton RM, Bus JS.
    Toxicol Appl Pharmacol; 1986 Oct 15; 86(1):93-104. PubMed ID: 3764938
    [Abstract] [Full Text] [Related]

  • 29. Enhanced melphalan cytotoxicity in human ovarian cancer in vitro and in tumor-bearing nude mice by buthionine sulfoximine depletion of glutathione.
    Ozols RF, Louie KG, Plowman J, Behrens BC, Fine RL, Dykes D, Hamilton TC.
    Biochem Pharmacol; 1987 Jan 01; 36(1):147-53. PubMed ID: 3801051
    [Abstract] [Full Text] [Related]

  • 30. Chemosensitization of L-phenylalanine mustard by the thiol-modulating agent buthionine sulfoximine.
    Kramer RA, Greene K, Ahmad S, Vistica DT.
    Cancer Res; 1987 Mar 15; 47(6):1593-7. PubMed ID: 3815359
    [Abstract] [Full Text] [Related]

  • 31. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K, Takahashi M, Nishidai T, Dodo Y, Shibamoto Y, Hiraoka M, Yukawa Y, Abe M.
    Radiat Med; 1984 Mar 15; 2(1):71-5. PubMed ID: 6242712
    [Abstract] [Full Text] [Related]

  • 32. Lack of enhanced antitumor efficacy for L-buthionine sulfoximine in combination with carmustine, cyclophosphamide, doxorubicin or melphalan in mice.
    Soble MJ, Dorr RT.
    Anticancer Res; 1988 Mar 15; 8(1):17-22. PubMed ID: 3358633
    [Abstract] [Full Text] [Related]

  • 33. L-buthionine-sulfoximine-mediated radiosensitization in experimental interstitial radiotherapy of intracerebral D-54 MG glioma xenografts in athymic mice.
    Lippitz BE, Halperin EC, Griffith OW, Colvin OM, Honore G, Ostertag CB, Bigner DD, Friedman HS.
    Neurosurgery; 1990 Feb 15; 26(2):255-60. PubMed ID: 2308673
    [Abstract] [Full Text] [Related]

  • 34. Phase I trial of buthionine sulfoximine in combination with melphalan in patients with cancer.
    O'Dwyer PJ, Hamilton TC, LaCreta FP, Gallo JM, Kilpatrick D, Halbherr T, Brennan J, Bookman MA, Hoffman J, Young RC, Comis RL, Ozols RF.
    J Clin Oncol; 1996 Jan 15; 14(1):249-56. PubMed ID: 8558205
    [Abstract] [Full Text] [Related]

  • 35. Radiosensitization by misonidazole during recovery of cellular thiols following depletion by BSO or DEM.
    McNally NJ, Soranson JA.
    Int J Radiat Oncol Biol Phys; 1989 May 15; 16(5):1331-4. PubMed ID: 2715087
    [Abstract] [Full Text] [Related]

  • 36. In vivo modulation of glutathione by buthionine sulfoximine: effect on marrow response to melphalan.
    Russo A, Tochner Z, Phillips T, Carmichael J, DeGraff W, Friedman N, Fisher J, Mitchell JB.
    Int J Radiat Oncol Biol Phys; 1986 Jul 15; 12(7):1187-9. PubMed ID: 3744938
    [Abstract] [Full Text] [Related]

  • 37. In vivo therapeutic potential of combination thiol depletion and alkylating chemotherapy.
    Siemann DW, Beyers KL.
    Br J Cancer; 1993 Dec 15; 68(6):1071-9. PubMed ID: 8260357
    [Abstract] [Full Text] [Related]

  • 38. Factors involved in depletion of glutathione from A549 human lung carcinoma cells: implications for radiotherapy.
    Biaglow JE, Varnes ME, Epp ER, Clark EP, Astor M.
    Int J Radiat Oncol Biol Phys; 1984 Aug 15; 10(8):1221-7. PubMed ID: 6469742
    [Abstract] [Full Text] [Related]

  • 39. The effects of buthionine sulphoximine (BSO) on glutathione depletion and xenobiotic biotransformation.
    Drew R, Miners JO.
    Biochem Pharmacol; 1984 Oct 01; 33(19):2989-94. PubMed ID: 6148944
    [Abstract] [Full Text] [Related]

  • 40. The radiation dose-response relationship in a human glioma xenograft and an evaluation of the influence of glutathione depletion by buthionine sulfoximine.
    Halperin EC, Brizel DM, Honore G, Sontag MR, Griffith OW, Bigner DD, Friedman HS.
    Int J Radiat Oncol Biol Phys; 1992 Oct 01; 24(1):103-9. PubMed ID: 1512145
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.